The effect of rosuvastatin on incident pneumonia

Statins may prevent pneumonia, according to a new study in CMAJ (Canadian Medical Association Journal). Researchers from Israel and the United States analyzed data from the JUPITER trial, a randomized, double-blind trial with placebo control groups conducted at 1315 sites in 26 countries to look at the use of the statin rosuvastatin in disease prevention. The trial involved 17 802 men aged 50 years or older and women aged 60 years or older without a history of heart disease or diabetes.

Patients were randomized to receive either a placebo or rosuvastatin, a statin used to treat high cholesterol levels and prevent heart disease. During a median follow-up period of almost two years, the researchers found that 214 people in the statin group compared with 257 people in the placebo group contracted pneumonia.

"Participants randomly assigned to receive had a modest reduction in the incidence of pneumonia compared with participants assigned to the ," writes Dr. Victor Novack, Soroka University Medical Center, Israel and coauthors.

"Although a number of observational studies have suggested a protective effect of statin use on the incidence of pneumonia and other infections, we are not aware of any evidence from prior randomized trials that specifically evaluated this question," state the authors.

The authors conclude that the "absolute risk reduction observed in this primary prevention setting was small, and the effects on infection may be greater in other settings."

More information: Paper online: www.cmaj.ca/lookup/doi/10.1503/cmaj.111017

add to favorites email to friend print save as pdf

Related Stories

Can a cholesterol drug prevent colon cancer?

Mar 22, 2011

Thomas Jefferson University has started recruiting patients for a new National Cancer Institute (NCI)-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent ...

Recommended for you

Trapping the Ebola virus in transit

2 hours ago

The deadly Ebola virus makes use of host mechanisms – including a specific type of membrane-bound calcium channel – to gain entry into the cell cytoplasm. LMU researchers now show that blocking this channel ...

Saudi reports 10 MERS deaths in a week

2 hours ago

Ten more people in Saudi Arabia have died from MERS over the past week, health ministry figures showed on Friday, after an international mission urged extra measures to combat the virus.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.